Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Copeptın as a Dısease Severıty Indıcator: A Prospectıve Case-Control Study

NCT06211985 is registered in ClinicalTrials.gov with Berker Okay as lead sponsor.

NCT NCT06211985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06211985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Copeptın as a Dısease Severıty Indıcator: A Prospectıve Case-Control Study
Lead sponsor
Berker Okay
Phase
Not applicable
Overall status
Completed
Start date
April 12, 2023
Completion date
November 2, 2023
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchitis, bronchopneumonia, lower respiratory tract and lung infections, ventilator lung